Metastatic axillary lymph node technetium-99m-MIBI imaging in primary breast cancer

Area of Science:

• Nuclear medicine imaging
• Oncology
• Radiopharmaceuticals

Background:

• Technetium-99m-MIBI scintimammography is established for primary breast cancer detection.
• Axillary lymph node status is critical for breast cancer staging and treatment decisions.

Purpose of the Study:

• To evaluate the utility of scintimammography in identifying axillary lymph node metastasis in breast cancer patients.
• To assess the diagnostic performance of scintimammography for axillary lymph node involvement.

Main Methods:

• Prospective study of 100 women with breast cancer scheduled for axillary dissection.
• 99mTc-MIBI scintimammography performed pre-operatively, including anterior and lateral views of the chest and axilla.
• Image interpretation by two blinded observers, with awareness of injection site to prevent false positives.

Main Results:

• Scintimammography demonstrated a sensitivity of 79.2% and specificity of 84.6% for detecting metastatic axillary lymph nodes.
• Positive predictive value was 82.6%, and negative predictive value was 81.5%.
• Out of 100 patients, 48 had positive nodes (180/502) and 52 had negative nodes (611/611).

Conclusions:

• Scintimammography exhibits good diagnostic accuracy for detecting axillary lymph node involvement in breast cancer.
• This imaging modality can be integrated into standard breast cancer evaluation with minor protocol adjustments.
• Findings support the use of scintimammography for comprehensive breast cancer staging.